Why Osteopathy is Still Relevant in 2025 Written by London School of Osteopathy March 18, 2025 5 Reasons Osteopathy is Still Relevant in 2025 Founded in 1874 by Andrew Taylor Still, an American physician and surgeon, Osteopathy is certainly not a new profession. The practice is based on the holistic view that to feel truly […]
Osteopathy and Sport Written by London School of Osteopathy July 26, 2025 The role of osteopathy and sport Osteopathy plays an important role in sport, offering a holistic and non-invasive approach to the prevention, management and rehabilitation of sports-related injuries. Athletes at all levels face increasing physical demands, therefore the need for effective injury treatment […]
Does Osteopathy Work? The Facts on Osteopathic Treatment Written by London School of Osteopathy August 29, 2025 Does Osteopathy work? The facts on Osteopathic treatment At the London School of Osteopathy, through both our teaching clinic and our courses, we hear this question a lot: does osteopathy work? Regardless of the medical discipline, patients are […]
In-hospital initiation of dapagliflozin did not significantly reduce the short-term risk of cardiovascular death or worsening heart failure (HF) in patients admitted for HF, although positive effects were seen when combining trial data, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.
Heart failure with preserved ejection fraction (HFpEF) appears to develop as a result of changes in the biology of a person’s internal fat tissue, according to the Adipokine Hypothesis, a new way of understanding how fat may impact the heart.
The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has developed a diagnostic platform that amplifies the unique optical signals of molecules by more than a hundred million times, enabling the precise detection and quantification of trace amounts of Alzheimer’s disease biomarkers in body fluids.
Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack.
Nearly a quarter of people over the age of 40 experience painful osteoarthritis, making it a leading cause of disability in adults.
A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood cancer.
Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, according to new research from The University of Texas MD Anderson Cancer Center.